<?xml version="1.0" encoding="UTF-8"?>
<results title="tropicalVirus">
 <result pre="half are mosquito-borne, including the heavily studied: yellow fever (YFV)," exact="West Nile" post="(WNV), dengue (DENV), Japanese encephalitis (JEV), and Zika (ZIKV)"/>
 <result pre="(YFV), West Nile (WNV), dengue (DENV), Japanese encephalitis (JEV), and" exact="Zika" post="(ZIKV) viruses, which will be the focus of this"/>
 <result pre="fever or encephalitis to potentially death. The 2015–2016 outbreak of" exact="ZIKV" post="in South America was also associated with microcephaly in"/>
 <result pre="few mosquito-borne flaviviruses (namely YFV, JEV, and DENV). However, the" exact="DENV" post="vaccine has shown limited efficacy against all DENV serotypes"/>
 <result pre="However, the DENV vaccine has shown limited efficacy against all" exact="DENV" post="serotypes [7,8] and resulted in injury to children in"/>
 <result pre="packaging [28,29]. It has recently been shown that dengue and" exact="ZIKV" post="NS2A recruits the viral genome by binding specifically to"/>
 <result pre="structures for capsid have been solved for ZIKV, JEV, and" exact="WNV" post="[35,42,43]. The DENV C structure is similar to that"/>
 <result pre="have been solved for ZIKV, JEV, and WNV [35,42,43]. The" exact="DENV" post="C structure is similar to that of the other"/>
 <result pre="an artifact of crystallization conditions. Initially, the three-dimensional structures of" exact="DENV" post="and WNV capsid were solved using NMR and crystallography"/>
 <result pre="of crystallization conditions. Initially, the three-dimensional structures of DENV and" exact="WNV" post="capsid were solved using NMR and crystallography respectively [42,46]."/>
 <result pre="regions within the N-terminal domain (first 18 residues) of the" exact="DENV" post="capsid resulted in very slow propagation of virus due"/>
 <result pre="example, L50 and L54 residues in the α2 helices of" exact="DENV" post="C dimers are necessary for the capsid protein’s association"/>
 <result pre="they can be either pro- or anti-viral. The presence of" exact="ZIKV" post="C in nucleoli has been associated with ribosomal stress"/>
 <result pre="localization of capsid in the nucleolus is not specific to" exact="ZIKV" post="as it has been shown for DENV, WNV, and"/>
 <result pre="A closer look into the effects of JEV C and" exact="DENV" post="C in the nucleolus indicated interactions with ribosome biogenesis"/>
 <result pre="factors such as B23 and NPM1 or nucleolin, respectively [21,56]." exact="WNV" post="capsid appears to sequester p53 inhibitor MDM2/HDM2 in the"/>
 <result pre="be considered anti-viral. However, it has also been shown that" exact="YFV" post="C has the ability to suppress the anti-viral RNA"/>
 <result pre="has also been shown to aid in the removal of" exact="WNV" post="C from the nucleolus and present the viral protein"/>
 <result pre="in human lung carcinoma cell lines such as H1299 [19]." exact="WNV" post="C has also been shown to up-regulate protein phosphatase"/>
 <result pre="alternative splicing, or decay of transcripts. In the case of" exact="DENV" post="serotype 1 in Huh7 cells, the largest changes observed"/>
 <result pre="observed were in differential isoforms, indicating alternative splicing [38]. However," exact="ZIKV" post="C has been shown to modulate the non-sense mediated"/>
 <result pre="their own signatures. Affinity purification and mass spectrometry determined that" exact="ZIKV" post="C interacts with various NMD proteins, including poly-A binding"/>
 <result pre="global transcriptome changes, but there has also been evidence of" exact="DENV" post="C binding core histones in the nucleus and death"/>
 <result pre="isothermal titration calorimetry assay to measure the binding affinity of" exact="ZIKV" post="C to four types of nucleic acid: 5′ UTR"/>
 <result pre="to four types of nucleic acid: 5′ UTR of the" exact="ZIKV" post="genome (ssRNA), dsRNA, ssDNA, and dsDNA, which may be"/>
 <result pre="be found in the nucleus. Interestingly their studies indicated that" exact="ZIKV" post="C bound all nucleic acids with affinities in the"/>
 <result pre="mosquitos, as noted previously [48], and others have shown that" exact="ZIKV" post="capsid’s ability to bind ssDNA is made possible by"/>
 <result pre="the specificity appears to be low. The dissociation constant for" exact="DENV" post="capsid is roughly 20 nM [15,17]. Considering the wide"/>
 <result pre="cell entry. One example is the small molecule inhibitor of" exact="DENV" post="C, ST-148 [68,69]. This small molecule binds in the"/>
 <result pre="with host proteins are also valuable targets (see Table 1)." exact="DENV" post="capsid binds nucleolin, as noted previously, disrupting ribosome biogenesis."/>
 <result pre="effective flavivirus antivirals [39]. In 2012, Martins et al. investigated" exact="DENV" post="capsid interactions to lipid droplets by producing peptides mimicking"/>
 <result pre="RecombiTEK (Merial) available since 2004, used to vaccinate horses against" exact="West Nile" post="virus. This recombinant virus uses canarypox as a vector"/>
 <result pre="This recombinant virus uses canarypox as a vector to express" exact="WNV" post="E and prM proteins. Interestingly there are multiple equine"/>
 <result pre="WNV E and prM proteins. Interestingly there are multiple equine" exact="WNV" post="vaccines commercially available: RecombiTEK, a live-attenuated vaccine, and a"/>
 <result pre="and a chimeric vaccine containing the 17D backbone but expressing" exact="WNV" post="E and prM [75]. All of these allow the"/>
 <result pre="of these allow the survival of all horses challenged with" exact="WNV" post="infection, compared to the devastating ~30% fatality rate seen"/>
 <result pre="available to humans. The two most notable are the live-attenuated" exact="YFV" post="17D vaccine and Dengvaxia (a tetravalent DENV chimeric vaccine),"/>
 <result pre="are the live-attenuated YFV 17D vaccine and Dengvaxia (a tetravalent" exact="DENV" post="chimeric vaccine), but there are also vaccines available for"/>
 <result pre="genes for the E and prM proteins from the different" exact="DENV" post="serotypes. It is a tetravalent vaccine, but has only"/>
 <result pre="culture or animal tissue until virulence greatly decreased [77,82]. The" exact="YFV" post="vaccine noted above, 17D, was generated roughly 80 years"/>
 <result pre="attenuation in 17D is its reduced genetic diversity within the" exact="YFV" post="quasi-species, indicating high fidelity caused by mutations within nonstructural"/>
 <result pre="of these attenuated viral genomes for many flaviviruses, including WNV," exact="ZIKV" post="and DENV [86,87,88]. These are initially produced in cells"/>
 <result pre="attenuated viral genomes for many flaviviruses, including WNV, ZIKV and" exact="DENV" post="[86,87,88]. These are initially produced in cells expressing wild-type/full-length"/>
 <result pre="This is common across the dengue serotypes and extends to" exact="Zika" post="virus as well [95,96]. Therefore, there may also be"/>
 <result pre="having a stabilizing effect, preventing uncoating and genome release of" exact="DENV" post="upon viral entry [69,70]. Of course, the canonical function"/>
 <result pre="the Arbovirus Vectors Aedes Aegypti and Ae. AlbopictusElife20154e0834710.7554/eLife.0834726126267 6.MingG.L.TangH.SongH.Advances in" exact="Zika" post="Virus Research: Stem Cell Models, Challenges, and OpportunitiesCell Stem"/>
 <result pre="Challenges, and OpportunitiesCell Stem Cell20161969070210.1016/j.stem.2016.11.01427912090 7.VillarL.DayanG.H.Arredondo-GarcíaJ.L.RiveraD.M.CunhaR.DesedaC.ReynalesH.CostaM.S.Morales-RamírezJ.O.CarrasquillaG.et al.Efficacy of a Tetravalent" exact="Dengue" post="Vaccine in Children in Latin AmericaN. Engl. J. Med.201537211312310.1056/NEJMoa141103725365753"/>
 <result pre="Engl. J. Med.201537211312310.1056/NEJMoa141103725365753 8.HadinegoroS.R.Arredondo-GarcíaJ.L.CapedingM.R.DesedaC.ChotpitayasunondhT.DietzeR.IsmailH.I.M.ReynalesH.LimkittikulK.Rivera-MedinaD.M.et al.Efficacy and Long-Term Safety of a" exact="Dengue" post="Vaccine in Regions of Endemic DiseaseN. Engl. J. Med.20153731195120610.1056/NEJMoa150622326214039"/>
 <result pre="contains a lipid-droplet-binding motifBiochem. J.201244440541510.1042/BJ2011221922428600 15.BykL.A.GamarnikA.V.Properties and Functions of the" exact="Dengue" post="Virus Capsid ProteinAnnu. Rev. Virol.2016326328110.1146/annurev-virology-110615-04233427501261 16.IglesiasN.G.MondotteJ.A.BykL.A.De MaioF.A.SamsaM.M.AlvarezC.GamarnikA.V.Dengue Virus Uses"/>
 <result pre="Virus ProductionJ. Virol.20199310.1128/JVI.00612-19 19.OhW.YangM.R.LeeE.W.ParkK.M.PyoS.YangJ.S.LeeH.W.SongJ.Jab1 Mediates Cytoplasmic Localization and Degradation of" exact="West Nile" post="Virus Capsid ProteinJ. Boil. Chem.2006281301663017410.1074/jbc.M602651200 20.SlomnickiL.P.ChungN.H.ParkerA.HermannT.BoydN.L.HetmanM.Ribosomal stress and Tp53-mediated"/>
 <result pre="Tp53-mediated neuronal apoptosis in response to capsid protein of the" exact="Zika" post="virusSci. Rep.201771665210.1038/s41598-017-16952-829192272 21.TsudaY.MoriY.AbeT.YamashitaT.OkamotoT.IchimuraT.MoriishiK.MatsuuraY.Nucleolar protein B23 interacts with Japanese encephalitis"/>
 <result pre="22.XuZ.AndersonR.HobmanT.C.The Capsid-Binding Nucleolar Helicase DDX56 Is Important for Infectivity of" exact="West Nile" post="VirusJ. Virol.2011855571558010.1128/JVI.01933-1021411523 23.YangM.R.LeeS.R.OhW.LeeE.W.YehJ.Y.NahJ.J.JooY.S.ShinJ.LeeH.W.PyoS.et al.West Nile Virus Capsid Protein Induces"/>
 <result pre="Virol.201084104381044710.1128/JVI.00986-1020686019 25.JunjhonJ.PenningtonJ.G.EdwardsT.J.PereraR.LanmanJ.KuhnR.J.Ultrastructural Characterization and Three-Dimensional Architecture of Replication Sites in" exact="Dengue" post="Virus-Infected Mosquito CellsJ. Virol.2014884687469710.1128/JVI.00118-1424522909 26.WelschS.MillerS.Romero-BreyI.MerzA.BleckC.K.WaltherP.FullerS.D.AntonyC.Krijnse-LockerJ.BartenschlagerR.Composition and Three-Dimensional Architecture of"/>
 <result pre="Virus-Infected Mosquito CellsJ. Virol.2014884687469710.1128/JVI.00118-1424522909 26.WelschS.MillerS.Romero-BreyI.MerzA.BleckC.K.WaltherP.FullerS.D.AntonyC.Krijnse-LockerJ.BartenschlagerR.Composition and Three-Dimensional Architecture of the" exact="Dengue" post="Virus Replication and Assembly SitesCell Host Microbe2009536537510.1016/j.chom.2009.03.00719380115 27.CorteseM.GoellnerS.AcostaE.G.NeufeldtC.J.OleksiukO.LampeM.HaselmannU.FunayaC.SchieberN.RonchiP.et al.Ultrastructural"/>
 <result pre="Replication and Assembly SitesCell Host Microbe2009536537510.1016/j.chom.2009.03.00719380115 27.CorteseM.GoellnerS.AcostaE.G.NeufeldtC.J.OleksiukO.LampeM.HaselmannU.FunayaC.SchieberN.RonchiP.et al.Ultrastructural Characterization of" exact="Zika" post="Virus Replication FactoriesCell Rep.2017182113212310.1016/j.celrep.2017.02.01428249158 28.KümmererB.M.RiceC.M.Mutations in the Yellow Fever"/>
 <result pre="RNA-interacting proteinsFEBS Lett.20115852575258110.1016/j.febslet.2011.06.03821771593 35.ShangZ.SongH.ShiY.QiJ.GaoG.F.Crystal Structure of the Capsid Protein from" exact="Zika" post="VirusJ. Mol. Biol.201843094896210.1016/j.jmb.2018.02.00629454707 36.BhuvanakanthamR.ChongM.K.NgM.L.Specific Interaction of Capsid Protein and"/>
 <result pre="Mol. Biol.201843094896210.1016/j.jmb.2018.02.00629454707 36.BhuvanakanthamR.ChongM.K.NgM.L.Specific Interaction of Capsid Protein and Importin-Alpha/Beta Influences" exact="West Nile" post="Virus ProductionBiochem. Biophys. Res. Commun.2009389636910.1016/j.bbrc.2009.08.10819712667 37.YangJ.S.RamanathanM.P.MuthumaniK.ChooA.Y.JinS.H.YuQ.C.HwangD.S.ChooD.K.LeeM.D.DangK.et al.Induction of Inflammation"/>
 <result pre="Virus ProductionBiochem. Biophys. Res. Commun.2009389636910.1016/j.bbrc.2009.08.10819712667 37.YangJ.S.RamanathanM.P.MuthumaniK.ChooA.Y.JinS.H.YuQ.C.HwangD.S.ChooD.K.LeeM.D.DangK.et al.Induction of Inflammation by" exact="West Nile" post="virus Capsid through the Caspase-9 Apoptotic PathwayEmerg. Infect. Dis.200281379138410.3201/eid0812.02022412498651"/>
 <result pre="Infect. Dis.200281379138410.3201/eid0812.02022412498651 38.SessionsO.M.TanY.GohK.C.LiuY.TanP.RozenS.OoiE.E.Host Cell Transcriptome Profile during Wild-Type and Attenuated" exact="Dengue" post="Virus InfectionPLoS Negl. Trop. Dis.20137e210710.1371/journal.pntd.000210723516652 39.SinghP.K.KhatriI.JhaA.PrettoC.D.SpindlerK.R.ArumugaswamiV.GiriS.KumarA.BhasinM.K.Determination of system level"/>
 <result pre="39.SinghP.K.KhatriI.JhaA.PrettoC.D.SpindlerK.R.ArumugaswamiV.GiriS.KumarA.BhasinM.K.Determination of system level alterations in host transcriptome due to" exact="Zika" post="virus (ZIKV) Infection in retinal pigment epitheliumSci. Rep.201881120910.1038/s41598-018-29329-230046058 40.EtebariK.HegdeS.SaldanaM.A.WidenS.G.WoodT.G.AsgariS.HughesG.L.Global"/>
 <result pre="40.EtebariK.HegdeS.SaldanaM.A.WidenS.G.WoodT.G.AsgariS.HughesG.L.Global transcriptome analysis of Aedes aegypti mosquitoes in response to" exact="Zika" post="virus infectionMSphere2017210.1128/mSphere.00456-17 41.YoshiiK.Epidemiology and pathological mechanisms of tick-borne encephalitisJ."/>
 <result pre="Coding Sequences Revealed a Requirement of the N-Terminal Region of" exact="Dengue" post="Virus Capsid Protein in Virus Particle FormationJ. Virol.2012861046105810.1128/JVI.05431-1122072762 46.MaL.JonesC.T.GroeschT.D.KuhnR.J.PostC.B.Solution"/>
 <result pre="RNAProc. Natl. Acad. Sci. USA2016113138631386810.1073/pnas.160054411327849599 49.LiT.ZhaoQ.YangX.ChenC.YangK.WuC.ZhangT.DuanY.XueX.MiK.et al.Structural Insight into the" exact="Zika" post="Virus Capsid Encapsulating the Viral GenomeCell Res.20182849749910.1038/s41422-018-0007-929467384 50.AllanJ.Participation of"/>
 <result pre="by RNA virus capsid proteinsCell. Signal.2008201227123610.1016/j.cellsig.2007.12.01818258415 56.BalinskyC.A.SchmeisserH.GanesanS.SinghK.PiersonT.C.ZoonK.C.Nucleolin Interacts with the" exact="Dengue" post="Virus Capsid Protein and Plays a Role in Formation"/>
 <result pre="in Formation of Infectious Virus ParticlesJ. Virol.201387130941310610.1128/JVI.00704-1324027323 57.VarjakM.DonaldC.L.MottramT.J.SreenuV.B.MeritsA.MaringerK.SchnettlerE.KohlA.Characterization of the" exact="Zika" post="virus induced small RNA response in Aedes aegypti cellsPLoS"/>
 <result pre="cellsPLoS Negl. Trop. Dis.201711e000601010.1371/journal.pntd.000601029040304 58.FontaineK.A.LeonK.E.KhalidM.M.TomarS.Jimenez-MoralesD.DunlapM.KayeJ.A.ShahP.S.FinkbeinerS.KroganN.J.et al.The Cellular NMD Pathway Restricts" exact="Zika" post="Virus Infection and Is Targeted by the Viral Capsid"/>
 <result pre="apoptosisVirus Res.201014727528310.1016/j.virusres.2009.11.01219944121 61.CoyaudE.RanadheeraC.ChengD.T.GoncalvesJ.DyakovB.J.A.LaurentE.M.N.St-GermainJ.R.PelletierL.GingrasA.C.BrumellJ.H.et al.Global Interactomics Uncovers Extensive Organellar Targeting by" exact="Zika" post="VirusMol. Cell. Proteom.2018172242225510.1074/mcp.TIR118.00080030037810 62.MacharaA.LuxV.KožíšekM.ŠaškováK.G.ŠtěpánekO.KotoraM.ParkanK.PávováM.GlassB.SehrP.et al.Specific Inhibitors of HIV Capsid"/>
 <result pre="antiviral designVirus Res.201216938841010.1016/j.virusres.2012.06.01622728445 65.AggarwalM.KaurR.SahaA.MudgalR.YadavR.DashP.K.ParidaM.KumarP.TomarS.Evaluation of antiviral activity of piperazine against" exact="Chikungunya" post="virus targeting hydrophobic pocket of alphavirus capsid proteinAntivir. Res.201714610211110.1016/j.antiviral.2017.08.01528842264"/>
 <result pre="in dengue drug discoveryAntivir. Res.201916810911310.1016/j.antiviral.2019.05.00531085207 69.ByrdC.M.DaiD.GrosenbachD.W.BerhanuA.JonesK.F.CardwellK.B.SchneiderC.WineingerK.A.PageJ.M.HarverC.et al.A Novel Inhibitor of" exact="Dengue" post="Virus Replication That Targets the Capsid ProteinAntimicrob. Agents Chemother.201357152510.1128/AAC.01429-1223070172"/>
 <result pre="Chemother.201357152510.1128/AAC.01429-1223070172 70.ScaturroP.TristI.M.L.PaulD.KumarA.AcostaE.G.ByrdC.M.JordanR.BrancaleA.BartenschlagerR.Characterization of the Mode of Action of a Potent" exact="Dengue" post="Virus Capsid InhibitorJ. Virol.201488115401155510.1128/JVI.01745-1425056895 71.BoonP.L.S.MartinsA.S.EnguitaF.J.LimX.N.SantosN.C.MatsudairaP.T.MartinsI.C.YueW.BondP.J.HuberR.G.Genome-Wide Associations of Flavivirus Capsid"/>
 <result pre="J. Med.201637495195810.1056/NEJMoa160065126862926 75.SeinoK.K.LongM.T.GibbsE.P.J.BowenR.A.BeachboardS.E.HumphreyP.P.DixonM.A.BourgeoisM.A.Comparative Efficacies of Three Commercially Available Vaccines against" exact="West Nile" post="Virus (WNV) in a Short-Duration Challenge Trial Involving an"/>
 <result pre="Virus (WNV) in a Short-Duration Challenge Trial Involving an Equine" exact="WNV" post="Encephalitis ModelClin. Vaccine Immunol.2007141465147110.1128/CVI.00249-0717687109 76.OstlundE.N.CromR.L.PedersenD.D.JohnsonD.J.WilliamsW.O.SchmittB.J.Equine West Nile Encephalitis, United"/>
 <result pre="Trial Involving an Equine WNV Encephalitis ModelClin. Vaccine Immunol.2007141465147110.1128/CVI.00249-0717687109 76.OstlundE.N.CromR.L.PedersenD.D.JohnsonD.J.WilliamsW.O.SchmittB.J.Equine" exact="West Nile" post="Encephalitis, United StatesEmerg. Infect. Dis.2001766566910.3201/eid0704.01741211589171 77.GallerR.FreireM.JaborA.MannG.The yellow fever 17D"/>
 <result pre="Mutants: Basics, Benefits, and BarriersViral Immunol.20041746147210.1089/vim.2004.17.46115671744 86.XieX.KumD.B.XiaH.LuoH.ShanC.ZouJ.MuruatoA.E.MedeirosD.B.NunesB.T.DallmeierK.et al.A Single-Dose Live-Attenuated" exact="Zika" post="Virus Vaccine with Controlled Infection Rounds that Protects against"/>
 <result pre="Rounds that Protects against Vertical TransmissionCell Host Microbe20182448749910.1016/j.chom.2018.09.00830308155 87.SchlickP.KoflerR.M.SchittlB.TaucherC.NagyE.MeinkeA.MandlC.W.Characterization of" exact="West Nile" post="virus live vaccine candidates attenuated by capsid deletion mutationsVaccine2010285903590910.1016/j.vaccine.2010.06.04520600500"/>
 <result pre="89.BarrettA.D.T.Flavivirus DNA vaccine with a kickNat. Biotechnol.20082652552610.1038/nbt0508-52518464782 90.BarrettA.D.T.Current status of" exact="Zika" post="vaccine development: Zika vaccines advance into clinical evaluationNPJ Vaccines201832410.1038/s41541-018-0061-929900012"/>
 <result pre="with a kickNat. Biotechnol.20082652552610.1038/nbt0508-52518464782 90.BarrettA.D.T.Current status of Zika vaccine development:" exact="Zika" post="vaccines advance into clinical evaluationNPJ Vaccines201832410.1038/s41541-018-0061-929900012 91.BeckettC.G.TjadenJ.BurgessT.DankoJ.R.TammingaC.SimmonsM.WuS.J.SunP.KochelT.RaviprakashK.et al.Evaluation of"/>
 <result pre="1 clinical trialVaccine20112996096810.1016/j.vaccine.2010.11.05021111785 92.GaudinskiM.R.HouserK.V.MorabitoK.M.HuZ.YamshchikovG.RothwellR.S.BerkowitzN.MendozaF.SaundersJ.G.NovikL.et al.Safety, Tolerability, and Immunogenicity of Two" exact="Zika" post="Virus DNA Vaccine Candidates in Healthy Adults: Randomised, Open-Label,"/>
 <result pre="93.ChangD.C.LiuW.J.AnrakuI.ClarkD.C.PollittC.C.SuhrbierA.HallR.A.KhromykhA.A.Single-round infectious particles enhance immunogenicity of a DNA vaccine against" exact="West Nile" post="virusNat. Biotechnol.20082657157710.1038/nbt140018425125 94.RobyJ.A.Bielefeldt-OhmannH.ProwN.A.ChangD.C.HallR.A.KhromykhA.A.Increased expression of capsid protein in trans"/>
 <result pre="protein in trans enhances production of single-round infectious particles by" exact="West Nile" post="virus DNA vaccine candidateJ. Gen. Virol.2014952176219110.1099/vir.0.064121-024958626 95.DejnirattisaiW.SupasaP.WongwiwatW.RouvinskiA.Barba-SpaethG.DuangchindaT.SakuntabhaiA.Cao-LormeauV.M.MalasitP.ReyF.A.et al.Dengue virus"/>
 <result pre="replication and assembly in flavivirusesCurr. Opin. Virol.2014913414210.1016/j.coviro.2014.09.02025462445 104.HasanS.S.SevvanaM.KuhnR.J.RossmannM.G.Structural biology of" exact="Zika" post="virus and other flavivirusesNat. Struct. Mol. Biol.201825132010.1038/s41594-017-0010-829323278 105.PaulD.BartenschlagerR.Flaviviridae Replication"/>
 <result pre="genome (blue line). Figure 2 Flavivirus capsid structure. (Top left)" exact="Zika" post="virus (ZIKV) C bottom view, 5YGH.pdb. (Top right) West"/>
 <result pre="left) Zika virus (ZIKV) C bottom view, 5YGH.pdb. (Top right)" exact="West Nile" post="virus (WNV) C bottom view. Color key provided bottom"/>
 <result pre="key provided bottom left, 1SFK.pdb. (Bottom right) side view of" exact="ZIKV" post="C dimer with its orientation to the lipid bilayer,"/>
</results>
